Cell & Gene Therapy

1. Gene Therapy Services 9/18/2025

   Fast-track your Gene Therapies from cutting-edge process development to commercial success with advanced viral vector manufacturing solutions!

2. Generation Of A Universal AAV Packaging Cell Line For Commercial Gene Therapy Manufacturing 9/4/2025

   Uncover the benefits of this CGMP-ready, stable AAV packaging cell line with proven expertise to reduce costs, streamline manufacturing, and make life-changing gene therapies more accessible to patients in need.

3. Development Of A Serotype-Agnostic AAV Platform For Suspension Cell Culture 9/4/2025

   To evaluate performance, we compared a suspension process with an adherent iCELLis (200 m²) system, assessing upstream and downstream recovery, as well as analytics using an AAV testing platform.

4. Lentiviral Vectors: The Key To Cell And Gene Therapy Success 7/30/2025

   Lentiviral vector manufacturing is complex and highly regulated, which is why a specialized CDMO is required to ensure safe, scalable, and compliant production from early development to commercialization.

5. AAV Viral Titering Using Nanoplate-Based Digital PCR 7/22/2025

   Examine how nanoplate-based digital PCR streamlines AAV titering, providing faster results and greater accuracy, advancing gene therapy development from the lab to the clinic.

6. SK pharmteco Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

   Our integrated expertise — from plasmid science to viral vector and cell therapy manufacturing — can accelerate and de-risk the development of your advanced therapies.

7. SK pharmteco Capacity Update April 2025: Analytical Services 4/22/2025

   Get the quality, compliance, and accelerated development support you need for your small molecule and cell and gene therapy program with our advanced analytical testing services.

8. cGMP-Ready Clonal HEK293 Cell Line For AAV, Lenti-, And Adenoviral Vectors 11/7/2024

   See how this advanced SKPT-HEK293 4G9 was able to provide a robust, CGMP-ready solution for efficient viral vector production, supporting a range of AAV serotypes and CAR-T Lenti-viral vectors for scalable manufacturing.

9. SK pharmteco Capacity Update October 2024: Cell & Gene Therapy 10/24/2024

   Check out our enhanced capacity and expertise in supporting CGT projects, offering end-to-end solutions from viral vector and plasmid development to GMP manufacturing and regulatory support.

10. Advancing Viral Vector Manufacturing: The Importance Of The Cell Line 9/16/2024

    Explore the pivotal role of cell lines in viral vector manufacturing, a complex, multi-step process that has traditionally been both time-consuming and labor-intensive.